# CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma

> **NCT03656705** · PHASE1 · COMPLETED · sponsor: **Henan Medical University** · enrollment: 2 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** CCCR-NK92 cells

## Key facts

- **NCT ID:** NCT03656705
- **Lead sponsor:** Henan Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-29
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2023-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03656705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03656705, "CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03656705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*